Interestingly, preincubation with exendin-(9–39) (GLP-1R antagonist) was able to inhibit exendin-4–mediated inhibition of MG-induced oxidative stress and mitochondrial dysfunction, but unable to inhibit GLP-1 (9–36) protective effects (Figure 6). The gene discussed is GCG; the disease is myasthenia gravis.